ASCO® 2024 Highlights: Presenter Vignette – Caroline Robert

Prof. Caroline Robert

Caroline Robert

MD, PhD

Gustave Roussy Cancer Campus

Abstract# LBA9503

Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced BRAF-V600E/K-mutated melanoma: The primary analysis of an EORTC randomized phase II study (EBIN).